Skip to main content

Standard Biotools Inc 10-Q for FY2026 Q3

Standard Biotools Inc. (LAB)

10-Q 2026-11-03 For: 2026-09-30
View Original
Added on November 03, 2026

About this 10-Q

Standard Biotools Inc filed this 10-Q on November 3, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Standard BioTools expects its merger with Treeline Biosciences to close in the fourth quarter of 2026, with existing shareholders holding approximately 16% of the combined company. Stockholders are scheduled to vote on November 19, 2026. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$19.39M
down 0.9% from $19.55M a year earlier
Net income
$13.48M
compared with a net loss of $34.69M a year earlier
Diluted EPS
$0.03
compared with -$0.09 a year earlier